153 related articles for article (PubMed ID: 28166272)
1. Activation of MAPK/ERK signaling by Burkholderia pseudomallei cycle inhibiting factor (Cif).
Ng MY; Wang M; Casey PJ; Gan YH; Hagen T
PLoS One; 2017; 12(2):e0171464. PubMed ID: 28166272
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of cellular effects of
Ng MY; Gan YH; Hagen T
Biol Open; 2018 Jul; 7(7):. PubMed ID: 29848489
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cullin RING ligases by cycle inhibiting factor: evidence for interference with Nedd8-induced conformational control.
Boh BK; Ng MY; Leck YC; Shaw B; Long J; Sun GW; Gan YH; Searle MS; Layfield R; Hagen T
J Mol Biol; 2011 Oct; 413(2):430-7. PubMed ID: 21903097
[TBL] [Abstract][Full Text] [Related]
4. In silico prediction of host-pathogen protein interactions in melioidosis pathogen Burkholderia pseudomallei and human reveals novel virulence factors and their targets.
Loaiza CD; Duhan N; Lister M; Kaundal R
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32444871
[TBL] [Abstract][Full Text] [Related]
5. Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family.
Cui J; Yao Q; Li S; Ding X; Lu Q; Mao H; Liu L; Zheng N; Chen S; Shao F
Science; 2010 Sep; 329(5996):1215-8. PubMed ID: 20688984
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the prevalence, secretion and function of a cell cycle-inhibiting factor in the melioidosis pathogen Burkholderia pseudomallei.
Pumirat P; Broek CV; Juntawieng N; Muangsombut V; Kiratisin P; Pattanapanyasat K; Stevens JM; Stevens MP; Korbsrisate S
PLoS One; 2014; 9(5):e96298. PubMed ID: 24809950
[TBL] [Abstract][Full Text] [Related]
7. Type III Secretion in the Melioidosis Pathogen
Vander Broek CW; Stevens JM
Front Cell Infect Microbiol; 2017; 7():255. PubMed ID: 28664152
[No Abstract] [Full Text] [Related]
8. Structural mechanism of ubiquitin and NEDD8 deamidation catalyzed by bacterial effectors that induce macrophage-specific apoptosis.
Yao Q; Cui J; Wang J; Li T; Wan X; Luo T; Gong YN; Xu Y; Huang N; Shao F
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20395-400. PubMed ID: 23175788
[TBL] [Abstract][Full Text] [Related]
9. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.
Galyov EE; Brett PJ; DeShazer D
Annu Rev Microbiol; 2010; 64():495-517. PubMed ID: 20528691
[TBL] [Abstract][Full Text] [Related]
10. DBSecSys 2.0: a database of Burkholderia mallei and Burkholderia pseudomallei secretion systems.
Memišević V; Kumar K; Zavaljevski N; DeShazer D; Wallqvist A; Reifman J
BMC Bioinformatics; 2016 Sep; 17():387. PubMed ID: 27650316
[TBL] [Abstract][Full Text] [Related]
11. The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease?
Lazar Adler NR; Govan B; Cullinane M; Harper M; Adler B; Boyce JD
FEMS Microbiol Rev; 2009 Nov; 33(6):1079-99. PubMed ID: 19732156
[TBL] [Abstract][Full Text] [Related]
12. Identification of a regulatory cascade controlling Type III Secretion System 3 gene expression in Burkholderia pseudomallei.
Sun GW; Chen Y; Liu Y; Tan GY; Ong C; Tan P; Gan YH
Mol Microbiol; 2010 May; 76(3):677-89. PubMed ID: 20345664
[TBL] [Abstract][Full Text] [Related]
13. Lipid A Remodeling Is a Pathoadaptive Mechanism That Impacts Lipopolysaccharide Recognition and Intracellular Survival of Burkholderia pseudomallei.
Norris MH; Somprasong N; Schweizer HP; Tuanyok A
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30037795
[No Abstract] [Full Text] [Related]
14. The Burkholderia pseudomallei Proteins BapA and BapC Are Secreted TTSS3 Effectors and BapB Levels Modulate Expression of BopE.
Treerat P; Alwis P; D'Cruze T; Cullinane M; Vadivelu J; Devenish RJ; Prescott M; Adler B; Boyce JD
PLoS One; 2015; 10(12):e0143916. PubMed ID: 26624293
[TBL] [Abstract][Full Text] [Related]
15. Functional characterizations of effector protein BipC, a type III secretion system protein, in Burkholderia pseudomallei pathogenesis.
Kang WT; Vellasamy KM; Chua EG; Vadivelu J
J Infect Dis; 2015 Mar; 211(5):827-34. PubMed ID: 25165162
[TBL] [Abstract][Full Text] [Related]
16. The serine protease inhibitor Ecotin is required for full virulence of Burkholderia pseudomallei.
Ireland PM; Marshall L; Norville I; Sarkar-Tyson M
Microb Pathog; 2014; 67-68():55-8. PubMed ID: 24462575
[TBL] [Abstract][Full Text] [Related]
17. The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei.
Burtnick MN; Brett PJ; Harding SV; Ngugi SA; Ribot WJ; Chantratita N; Scorpio A; Milne TS; Dean RE; Fritz DL; Peacock SJ; Prior JL; Atkins TP; Deshazer D
Infect Immun; 2011 Apr; 79(4):1512-25. PubMed ID: 21300775
[TBL] [Abstract][Full Text] [Related]
18. The bacterial effector Cif interferes with SCF ubiquitin ligase function by inhibiting deneddylation of Cullin1.
Morikawa H; Kim M; Mimuro H; Punginelli C; Koyama T; Nagai S; Miyawaki A; Iwai K; Sasakawa C
Biochem Biophys Res Commun; 2010 Oct; 401(2):268-74. PubMed ID: 20850415
[TBL] [Abstract][Full Text] [Related]
19. Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model.
Warawa J; Woods DE
FEMS Microbiol Lett; 2005 Jan; 242(1):101-8. PubMed ID: 15621426
[TBL] [Abstract][Full Text] [Related]
20. The extracellular signal-regulated kinase-mitogen-activated protein kinase pathway phosphorylates and targets Cdc25A for SCF beta-TrCP-dependent degradation for cell cycle arrest.
Isoda M; Kanemori Y; Nakajo N; Uchida S; Yamashita K; Ueno H; Sagata N
Mol Biol Cell; 2009 Apr; 20(8):2186-95. PubMed ID: 19244340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
